 |
|
|
| |
Daclatasvir Pharmacokinetics in Healthy Subjects: No Clinically Relevant Drug-Drug Interaction With Either Cyclosporine or Tacrolimus
|
| |
| |
Reported by Jules Levin, AASLD 2013 Nov 1-5 Wash DC
Bifano M,1 Adamczyk R,1 Hwang C,1 Kandoussi H,2 Marion A,3 Bertz RJ1
1Bristol-Myers Squibb, Hopewell, NJ; 2Bristol-Myers Squibb, Lawrenceville, NJ; 3ICON Development Solutions, Omaha, NE
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C - (11/25/13)
Drug-drug interactions with oral anti-HCV agents and Idiosyncratic Hepatotoxicity in the Liver Transplant setting - (11/25/13)
|
| |
|
|
|
|
|
